Literature DB >> 6149642

Determination of GOT activity on nucleation and crystal growth of calcium oxalate.

R Azoury, S Sarig, N Garti, S Perlberg, A D Randolph, G W Drach.   

Abstract

Crystal Size Distribution (CSD) and the yield of Calcium Oxalate Crystals in solutions with an admixture of 5 normal and 3 stone forming urines, were determined. A positive correlation was found between the median size, the number of particles and the overall inhibitory potentials of the urines toward calcium oxalate precipitation in vitro as reflected by Discriminating Index (DI) measurements. Incubation of two samples of stone formers' (SF) urines with glutamic-oxalacetic-transaminase (GOT) caused a reduction of aspartic acid concentration, an increase in glutamic acid concentration and a parallel decrease in the DI values. After 90 min of SF urine incubation with GOT the DI in three samples was improved and both the median size and number of particles reduced, by 28% and 45% respectively. These results could indicate that GOT activity changes the inhibitory power of the SF urine by transforming aspartic acid into glutamic acid, having thus most probably a part in the inhibition of CaOx stone formation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6149642     DOI: 10.1007/bf00256808

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  10 in total

1.  Growth of calcium oxalate crystals. I. A model for urinary stone growth.

Authors:  J L Meyer; L H Smith
Journal:  Invest Urol       Date:  1975-07

2.  Inhibition of calcium oxalate dihydrate crystallization by chemical modifiers: I. Pyrophosphate and methylene blue.

Authors:  G W Drach; A D Randolph; J D Miller
Journal:  J Urol       Date:  1978-01       Impact factor: 7.450

Review 3.  Calcium-containing renal stones.

Authors:  L H Smith
Journal:  Kidney Int       Date:  1978-05       Impact factor: 10.612

4.  Calcium oxalate crystalluria and inhibitors of crystallization in recurrent renal stone-formers.

Authors:  W G Robertson; M Peacock
Journal:  Clin Sci       Date:  1972-10       Impact factor: 6.124

5.  A method for discrimination between calcium oxalate kidney stone formers and normals.

Authors:  S Sarig; N Garti; R Azoury; Y Wax; S Perlberg
Journal:  J Urol       Date:  1982-09       Impact factor: 7.450

6.  Follow-up of drug therapy efficacy to prevent recurrence of calcium oxalate kidney stone formation.

Authors:  S Sarig; N Garti; R Azoury; S Perlberg; Y Wax
Journal:  J Urol       Date:  1983-06       Impact factor: 7.450

7.  May enzyme activity in urine play a role in kidney stone formation?

Authors:  R Azoury; N Garti; S Perlberg; S Sarig
Journal:  Urol Res       Date:  1982

8.  Effects of urinary organic macromolecules on crystallization of calcium oxalate: enhancement of nucleation.

Authors:  G W Drach; S Thorson; A Randolph
Journal:  J Urol       Date:  1980-04       Impact factor: 7.450

9.  Retardation of calcium oxalate precipitation by glutamic-oxalacetic-transaminase activity.

Authors:  R Azoury; S Sarig; N Garti; S Perlberg
Journal:  Urol Res       Date:  1982

10.  Citrate in urine and serum and associated variables in subgroups of urolithiasis. Results from an outpatient stone clinic.

Authors:  P O Schwille; D Scholz; K Schwille; R Leutschaft; I Goldberg; A Sigel
Journal:  Nephron       Date:  1982       Impact factor: 2.847

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.